Search Results - martha+zeiger

4 Results

Sort By:

Unmet NeedThyroid cancer is the most common malignancy of the endocrine system, representing 2.9% of all new cancer cases in the United States and is the fifth most common cancer in women. Every year, about 12,000 men and 35,000 women are diagnosed with thyroid cancer, and more than 900 men and 1,100 women die from the disease. Although fine needle...

Published: 7/5/2024 | Inventor(s): Christopher Umbricht, Yongchun Wang, Martha Zeiger

Keywords(s):

Category(s): Technology Classifications > Diagnostics > Biomarkers, Clinical and Disease Specializations > Oncology > Thyroid Cancer

Seventy Two Gene Model for 8 Thyroid Tumor Types

C10073: Seventy Two Gene Model for 8 Thyroid Tumor Types Value Proposition: Thyroid cancer represents 90% of all neuroendocrine malignancies with an estimated annual incidence of 122,800 cases worldwide. Currently, the most useful tool for the diagnosis of thyroid cancer is Fine-needle aspiration biopsy (FNA). This current method is extremely useful...

Published: 7/4/2024 | Inventor(s): Steven Libutti, Martha Zeiger, Nijaguna Prasad, Christopher Umbricht

Keywords(s): Biomarker, Cancers, Clinical Diagnostics, Diagnostic Biomarker, Disease Indication, In Vitro Diagnostics, Thyroid Cancer

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Endocrinology, Clinical and Disease Specializations > Oncology > Thyroid Cancer, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Diagnostics > Diagnostic Biomarkers, Technology Classifications > Diagnostics > In Vitro Diagnostics, Technology Classifications > Diagnostics, Clinical and Disease Specializations > Oncology

Alternative Splice Variant Patterns of Human Telomerase Reverse Transcriptase (hTERT) in Thyroid Tumors Distinguish Benign from Malignant

C05018: Alternative Splice Variant Patterns of Human Telomerase Reverse Transcriptase (hTERT) in Thyroid Tumors Distinguish Benign from Malignant Technical Details: Human telomerase reverse transcriptase (hTERT) is activated in thyroid cancer. Despite this, its usefulness as a marker in the distinction of benign from malignant neoplasm has not been...

Published: 7/4/2024 | Inventor(s): Yongchun Wang, Christopher Umbricht, Jeanne Kowalski, Martha Zeiger

Keywords(s): Biomarker, Cancers, Clinical Diagnostics, Diagnostic Biomarker, Disease Indication, In Vitro Diagnostics, Thyroid Cancer

Diagnostic Tool for Diagnosing Benign Versus Malignant Thyroid Lesions

C04567: Diagnostic Tool for Diagnosing Benign Versus Malignant Thyroid Lesions Technical Details: Thyroid cancer represents 1% of all malignant diseases and it is estimated that 5-10% of the population will develop a clinically significant thyroid nodule during their lifetime. The best available test for thyroid nodule is fine needle aspiration biopsy...

Published: 7/4/2024 | Inventor(s): Steven Libutti, Chiara Mazzanti, Christopher Umbricht, Martha Zeiger

Keywords(s): Biomarker, Cancers, Clinical Diagnostics, Diagnostic Biomarker, Disease Indication, In Vitro Diagnostics, Thyroid Cancer